"...it would have given Virax a nice boost had it gone through."
Agreed, stampeze. I would have expected 20pc lift in VHL shares.
Today the shares fell 10pc.
Transgene shares fell more, around 20pc before partially recovering.
I assume Transgene will consult manufacturing partner Sanofi about commercialization of TG-4010.
Meantime, I notice that the name Novartis is missing from today's announcement re the appointment of Dr Jason Smythe as a consultant on options for the Co-EX-GENE platform.
Perhaps VHL chairman, Dr Wayne Millen, will tomorrow confirm Novartis's decision not exercise its TG-4010 commercialization option. And comment on the implications.
- Forums
- ASX - By Stock
- VHL
- novartis doesn't take up transgene option
VHL
vitasora health limited
Add to My Watchlist
0.00%
!
2.8¢

novartis doesn't take up transgene option, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.11M |
Open | High | Low | Value | Volume |
2.8¢ | 2.8¢ | 2.7¢ | $4.424K | 160.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 348886 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 10576 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 348886 | 0.027 |
6 | 1545251 | 0.026 |
8 | 329423 | 0.025 |
4 | 417000 | 0.024 |
1 | 152000 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 10576 | 1 |
0.029 | 510563 | 2 |
0.030 | 944470 | 5 |
0.031 | 628000 | 2 |
0.032 | 1000000 | 2 |
Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
Featured News
VHL (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online